Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 12:11:1393673.
doi: 10.3389/fnut.2024.1393673. eCollection 2024.

Role of antioxidants supplementation in the treatment of atopic dermatitis: a critical narrative review

Affiliations
Review

Role of antioxidants supplementation in the treatment of atopic dermatitis: a critical narrative review

Edoardo De Simoni et al. Front Nutr. .

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by itching, epidermal barrier dysfunction, and an unbalanced inflammatory reaction. AD pathophysiology involves a dysregulated immune response driven by T helper-2 cells. Many factors, including reactive oxygen species (ROS), are involved in AD pathogenesis by causing cellular damage and inflammation resulting in skin barrier dysfunction. This narrative review aims to provide a comprehensive overview of the role of natural molecules and antioxidant compounds, highlighting their potential therapeutic value in AD prevention and management. They include vitamin D, vitamin E, pyridoxine, Vitamin C, carotenoids, and melatonin. Some studies report a statistically significant association between antioxidant levels and improvement in AD, however, there are conflicting results in which antioxidant supplementation, especially Vitamin D, did not result in improvement in AD. Therefore, the clinical efficacy of these dietary nutritional factors in the treatment of AD needs to be further evaluated in clinical trials. Meanwhile, antioxidants can be incorporated into the management of AD patients in a personalized manner, tailored to the severity of the disease, comorbidities, and individual needs.

Keywords: antioxidant supplementation; atopic dermatitis; atopic eczema; exogenous antioxidants; oxidative stress; reactive oxygen species; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Oxidative stress-mediated inflammatory pathway in AD. Oxidative stress causes direct damage to cell membranes by the activation of programmed cell death mechanims, resulting in the disruption of the skin barrier. As a result, inflammatory cytokines including IL-4, IL-13, IL-22, IL-31 and IgE are released, leading to further ROS production, establishing a vicious cycle that underlies the pathogenesis of AD. Therefore, the balance between oxidants and antioxidants may avoid the overproduction of ROS in the skin and is influenced by environmental factors (exogenous oxidants and antioxidants). Created with Biorender.com. IL, Interleukin; ROS, reactive oxygen species.

References

    1. Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. (2020) 396:345–60. doi: 10.1016/S0140-6736(20)31286-1 - DOI - PubMed
    1. Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. . Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. (2018) 73:1284–93. doi: 10.1111/all.13401 - DOI - PubMed
    1. Naldi L, Parazzini F, Gallus S. Prevalence of atopic dermatitis in Italian schoolchildren: factors affecting its variation. Acta Derm Venereol. (2008) 89:122–5. doi: 10.2340/00015555-0591, PMID: - DOI - PubMed
    1. Newsom M, Bashyam AM, Balogh EA, Feldman SR, Strowd LC. New and emerging systemic treatments for atopic dermatitis. Drugs. (2020) 80:1041–52. doi: 10.1007/s40265-020-01335-7, PMID: - DOI - PMC - PubMed
    1. Nakashima C, Yanagihara S, Otsuka A. Innovation in the treatment of atopic dermatitis: emerging topical and oral Janus kinase inhibitors. Allergol Int. (2022) 71:40–6. doi: 10.1016/j.alit.2021.10.004, PMID: - DOI - PubMed

LinkOut - more resources